MDAI vs GXAI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

MDAI

45.7
AI Score
VS
MDAI Wins

GXAI

43.5
AI Score

Investment Advisor Scores

MDAI

46score
Recommendation
HOLD

GXAI

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDAI GXAI Winner
Revenue 3.99M 1.81M MDAI
Net Income -3.41M -2.17M GXAI
Net Margin -85.5% -120.1% MDAI
Operating Income -1.97M -2.55M MDAI
ROE 38.7% -13.6% MDAI
ROA -19.2% -13.7% GXAI
Total Assets 17.73M 15.82M MDAI
Cash 11.70M 1.51M MDAI
Current Ratio 0.75 21.35 GXAI

Relative Price Performance (Last 90 Days)

MDAI 1M: -12.9% · 3M: -24.4% GXAI 1M: -35.9% · 3M: -40.9%

Current Technical Phase

MDAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 37

RSI (14): 36.9 · Price: $1.55

GXAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.0%), weak momentum, RSI 17

RSI (14): 16.8 · Price: $0.75

Fundamentals Snapshot

Metric MDAI GXAI
Market Cap
Forward P/E -4.5 -1.5
Trailing P/E
Revenue (TTM)
Revenue Growth -0.4% 75.2%
Gross Margin 0.5% 1.0%
Operating Margin -0.5% -1.4%
EPS -0.51 -0.62
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDAI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.